Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Corvidane Logo
Corvidane CB Rank
453523
Heat Score
53
Corvidane is a pharmaceutical manufacturing company that treats metabolic and inflammatory diseases.
Founded
obfuscation
Private New York, New York, United States1-10 www.corvidane.com
Manufacturing
Pharmaceutical
Therapeutics
Overview

Corvidane
Heat Score
53

Growth Score
pts
in past quarter
Heat Score 53
-12 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Corvidane

CB Rank
453523
Corvidane is a pharmaceutical manufacturing company that treats metabolic and inflammatory diseases.
Founded
obfuscation
Private New York, New York, United States1-10 www.corvidane.com
Manufacturing
Pharmaceutical
Therapeutics

Key People

Details

Operating Status Active
Company Type For Profit
Founders  Damion J. Boyer, John M. Burke
Contact Email info@Corvidane.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Corvida™ for Atherosclerosis
An oral adjunct therapy designed to treat atherosclerosis by targeting high-risk plaques in arterial walls alongside statin treatment.
Corvida™ for MASLD/MASH
An oral drug in development for treating Metabolic Dysfunction-Associated Steatotic Liver Disease and SteatoHepatitis, including patients with or without Type 2 Diabetes.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 2

Employee Profiles

News
Technology
View Tech Report

Active Website Tech Count

9Corvidane is actively using 9 technologies for its website, according to BuiltWith. These include Common Crawl, DNSSEC, and  Mobile Non Scaleable Content.
Sub-Organizations
Frequently Asked Questions

Where is Corvidane's headquarters? Corvidane is located in New York, New York, United States.Who are Corvidane's competitors? Alternatives and possible competitors to Corvidane may include Eli Lilly, Novo Nordisk, and  Madrigal Pharmaceuticals.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|